Serum BICC1 levels are significantly different in various mood disorders

Suzhen Chen,1,2 Haitang Jiang,1,2 Zhi Xu,1,2 Jingjing Zhao,3 Ming Wang,4 Yan Lu,5 Jianhua Li,6 Fei Sun,7 Yonggui Yuan1,2 1Department of Psychosomatics and Psychiatry, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing 210009, PR China; 2Institute of Psychosomatics, School of Medici...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Chen S, Jiang H, Xu Z, Zhao J, Wang M, Lu Y, Li J, Sun F, Yuan Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	mood disorder diagnosis differential diagnosis objective tool BICC1 Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/d28bd593dca441c0a53b33e48fe2b41d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d28bd593dca441c0a53b33e48fe2b41d
record_format	dspace
spelling	oai:doaj.org-article:d28bd593dca441c0a53b33e48fe2b41d2021-12-02T04:47:16ZSerum BICC1 levels are significantly different in various mood disorders1178-2021https://doaj.org/article/d28bd593dca441c0a53b33e48fe2b41d2019-01-01T00:00:00Zhttps://www.dovepress.com/serum-bicc1-levels-are-significantly-different-in-various-mood-disorde-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Suzhen Chen,1,2 Haitang Jiang,1,2 Zhi Xu,1,2 Jingjing Zhao,3 Ming Wang,4 Yan Lu,5 Jianhua Li,6 Fei Sun,7 Yonggui Yuan1,2 1Department of Psychosomatics and Psychiatry, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing 210009, PR China; 2Institute of Psychosomatics, School of Medicine, Southeast University, Nanjing 210009, PR China; 3Department of Psychiatry, Brain Hospital, Nanjing Medical University, Nanjing 210029, PR China; 4Department of Psychiatry, The Third People’s Hospital of Changshu, Suzhou 215500, PR China; 5Department of Psychiatry, The Fourth People’s Hospital of Zhangjiagang, Suzhou 215600, PR China; 6Department of Psychiatry, The Third People’s Hospital of Huzhou, Huzhou 313000, PR China; 7Department of Psychiatry, The Second People’s Hospital of Jingjiang, Taizhou 214500, PR China Purpose: Mood disorders are recurrent chronic disorders with fluctuating mood states and energy, and misdiagnosis is common when based solely on clinical interviews because of overlapping symptoms. Because misdiagnosis may lead to inappropriate treatment and poor prognosis, finding an easily implemented objective tool for the discrimination of different mood disorders is very necessary and urgent. However, there has been no accepted objective tool until now. Recently, BICC1 has been identified as a candidate gene relating to major depressive disorder (MDD). Therefore, the aim of this study is to evaluate the ability of serum BICC1 to discriminate between various mood disorders, including MDD and the manic and depressive phases of bipolar disorder, namely bipolar mania (BM) and bipolar depression (BD). Patients and methods: Serum BICC1 levels in drug-free patients with MDD (n=30), BM (n=30), and BD (n=13), and well-matched healthy controls (HC, n=30) were measured with ELISA kits. Pearson correlation analyses were used to analyze the correlations between serum BICC1 levels and clinical information. Receiver operating characteristic (ROC) curve analysis was used to analyze the differential discriminative potential of BICC1 for different mood disorders. Results: One-way ANOVA indicated that serum BICC1 levels were significantly increased in all patient groups compared with the HC group and significantly different between each pair of patient groups. Correlation analyses found no relationship between serum BICC1 levels and any clinical variables in any study group. ROC curve analysis showed that serum BICC1 could discriminate among all three mood disorders from each other accurately with fair-to-excellent discriminatory capacity (area under the ROC curve from 0.787 to 1.0). Conclusion: The findings of this preliminary study indicated significant differences in serum BICC1 levels in patients with different mood disorders. This study provides preliminary evidence that serum BICC1 may be regarded as a promising, objective, easy-to-use tool for diagnosing different mood disorders. Keywords: biomarker, mood disorder, diagnosis, differential diagnosis, objective tool, BICC1Chen SJiang HXu ZZhao JWang MLu YLi JSun FYuan YDove Medical Pressarticlemood disorderdiagnosisdifferential diagnosisobjective toolBICC1Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 15, Pp 259-265 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	mood disorder diagnosis differential diagnosis objective tool BICC1 Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	mood disorder diagnosis differential diagnosis objective tool BICC1 Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Chen S Jiang H Xu Z Zhao J Wang M Lu Y Li J Sun F Yuan Y Serum BICC1 levels are significantly different in various mood disorders
description	Suzhen Chen,1,2 Haitang Jiang,1,2 Zhi Xu,1,2 Jingjing Zhao,3 Ming Wang,4 Yan Lu,5 Jianhua Li,6 Fei Sun,7 Yonggui Yuan1,2 1Department of Psychosomatics and Psychiatry, ZhongDa Hospital, School of Medicine, Southeast University, Nanjing 210009, PR China; 2Institute of Psychosomatics, School of Medicine, Southeast University, Nanjing 210009, PR China; 3Department of Psychiatry, Brain Hospital, Nanjing Medical University, Nanjing 210029, PR China; 4Department of Psychiatry, The Third People’s Hospital of Changshu, Suzhou 215500, PR China; 5Department of Psychiatry, The Fourth People’s Hospital of Zhangjiagang, Suzhou 215600, PR China; 6Department of Psychiatry, The Third People’s Hospital of Huzhou, Huzhou 313000, PR China; 7Department of Psychiatry, The Second People’s Hospital of Jingjiang, Taizhou 214500, PR China Purpose: Mood disorders are recurrent chronic disorders with fluctuating mood states and energy, and misdiagnosis is common when based solely on clinical interviews because of overlapping symptoms. Because misdiagnosis may lead to inappropriate treatment and poor prognosis, finding an easily implemented objective tool for the discrimination of different mood disorders is very necessary and urgent. However, there has been no accepted objective tool until now. Recently, BICC1 has been identified as a candidate gene relating to major depressive disorder (MDD). Therefore, the aim of this study is to evaluate the ability of serum BICC1 to discriminate between various mood disorders, including MDD and the manic and depressive phases of bipolar disorder, namely bipolar mania (BM) and bipolar depression (BD). Patients and methods: Serum BICC1 levels in drug-free patients with MDD (n=30), BM (n=30), and BD (n=13), and well-matched healthy controls (HC, n=30) were measured with ELISA kits. Pearson correlation analyses were used to analyze the correlations between serum BICC1 levels and clinical information. Receiver operating characteristic (ROC) curve analysis was used to analyze the differential discriminative potential of BICC1 for different mood disorders. Results: One-way ANOVA indicated that serum BICC1 levels were significantly increased in all patient groups compared with the HC group and significantly different between each pair of patient groups. Correlation analyses found no relationship between serum BICC1 levels and any clinical variables in any study group. ROC curve analysis showed that serum BICC1 could discriminate among all three mood disorders from each other accurately with fair-to-excellent discriminatory capacity (area under the ROC curve from 0.787 to 1.0). Conclusion: The findings of this preliminary study indicated significant differences in serum BICC1 levels in patients with different mood disorders. This study provides preliminary evidence that serum BICC1 may be regarded as a promising, objective, easy-to-use tool for diagnosing different mood disorders. Keywords: biomarker, mood disorder, diagnosis, differential diagnosis, objective tool, BICC1
format	article
author	Chen S Jiang H Xu Z Zhao J Wang M Lu Y Li J Sun F Yuan Y
author_facet	Chen S Jiang H Xu Z Zhao J Wang M Lu Y Li J Sun F Yuan Y
author_sort	Chen S
title	Serum BICC1 levels are significantly different in various mood disorders
title_short	Serum BICC1 levels are significantly different in various mood disorders
title_full	Serum BICC1 levels are significantly different in various mood disorders
title_fullStr	Serum BICC1 levels are significantly different in various mood disorders
title_full_unstemmed	Serum BICC1 levels are significantly different in various mood disorders
title_sort	serum bicc1 levels are significantly different in various mood disorders
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/d28bd593dca441c0a53b33e48fe2b41d
work_keys_str_mv	AT chens serumbicc1levelsaresignificantlydifferentinvariousmooddisorders AT jiangh serumbicc1levelsaresignificantlydifferentinvariousmooddisorders AT xuz serumbicc1levelsaresignificantlydifferentinvariousmooddisorders AT zhaoj serumbicc1levelsaresignificantlydifferentinvariousmooddisorders AT wangm serumbicc1levelsaresignificantlydifferentinvariousmooddisorders AT luy serumbicc1levelsaresignificantlydifferentinvariousmooddisorders AT lij serumbicc1levelsaresignificantlydifferentinvariousmooddisorders AT sunf serumbicc1levelsaresignificantlydifferentinvariousmooddisorders AT yuany serumbicc1levelsaresignificantlydifferentinvariousmooddisorders
_version_	1718401036397314048

Serum BICC1 levels are significantly different in various mood disorders

Ejemplares similares